MRI predictors of cognitive outcome in early multiple sclerosis
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To determine MRI predictors for cognitive outcome in patients with early relapsing-remitting multiple sclerosis (MS).
Methods: Forty-four patients recently diagnosed with clinically definite MS were followed up with clinical and cognitive evaluations at 1, 2, 5, and 7 years and underwent brain MRI including magnetization transfer (MT) imaging at baseline and 2 years. Cognitive evaluation was also performed in 56 matched healthy subjects at baseline. Cognitive testing included the Brief Repeatable Battery. Imaging parameters included lesion load, brain parenchymal fraction (BPF), ventricular fraction (VF), and mean MT ratio (MTR) of lesion and normal-appearing brain tissue (NABT) masks.
Results: At baseline, patients presented deficits of memory, attention, and information processing speed (IPS). Over 2 years, all magnetic resonance parameters deteriorated significantly. Over 7 years, Expanded Disability Status Scale score deteriorated significantly. Fifty percent of patients deteriorated on memory cognitive domain and 22.7%of patients on IPS domain. Seven-year change of memory scores was significantly associated with baseline diffuse brain damage (NABT MTR). IPS z score change over 7 years was correlated with baseline global atrophy (BPF), baseline diffuse brain damage, and central brain atrophy (VF) change over 2 years.
Conclusion: The main predictors of cognitive changes over 7 years are baseline diffuse brain damage and progressive central brain atrophy over the 2 years after MS diagnosis.
Footnotes
Study funding: Supported in part by research grants from Association pour la Recherche contre la Sclérose en Plaques (ARSEP, France) and Bayer Healthcare France SA. Sponsors did not participate in design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.
-
- BPF
- brain parenchymal fraction
- BRB
- Brief Repeatable Battery
- CDMS
- clinically definite multiple sclerosis
- CI
- confidence interval
- CIS
- clinically isolated syndrome
- DR
- delayed recall
- EDSS
- Expanded Disability Status Scale
- IPS
- information processing speed
- LL
- lesion load
- LTS
- long-term storage
- MADRS
- Montgomery-Åsberg Depression Rating Scale
- MR
- magnetic resonance
- MS
- multiple sclerosis
- MSFC
- Multiple Sclerosis Functional Composite
- MT
- magnetization transfer
- MTR
- magnetization transfer ratio
- NABT
- normal-appearing brain tissue
- OR
- odds ratio
- PASAT
- Paced Auditory Serial Addition Test
- PCI
- patient cognitively impaired
- PCU
- patient cognitively unimpaired
- RRMS
- relapsing-remitting multiple sclerosis
- SDMT
- Symbol Digit Modalities Test
- SPART
- Spatial Recall Test
- SRT
- Selective Reminding Test
- SRT-CLTR
- consistent long-term retrieval
- TE
- echo time
- TI
- inversion time
- TR
- repetition time
- VF
- ventricular fraction
- WLG
- Word List Generation
-
Supplemental data at www.neurology.org
- Received May 18, 2010.
- Accepted December 22, 2010.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Responsiveness and predictive value of EDSS and MSFC in primary progressive MSJ. J. Kragt, A. J. Thompson, X. Montalban et al.Neurology, January 09, 2008 -
Articles
The Multiple Sclerosis Functional CompositeA clinically meaningful measure of disabilityChris H. Polman, Richard A. Rudick et al.Neurology, April 26, 2010 -
Article
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patientsGavin Giovannoni, Jeffrey A. Cohen, Alasdair J. Coles et al.Neurology, October 12, 2016 -
Articles
Comparisons of patient self-report, neurologic examination, and functional impairment in MSE.L.J. Hoogervorst, L.M.L. van Winsen, M.J. Eikelenboom et al.Neurology, April 10, 2001